SECTION 1. Notwithstanding any general or special law to the contrary, there shall be a special commission to study and provide recommendations on the feasibility of Massachusetts implementing a drug repository program for high cost pharmaceuticals, excluding Schedule I and Schedule II controlled substances.
The special commission shall examine the implementation of successful drug repository programs in other states and determine the possibility of establishing a similar program in the commonwealth. The study shall include determining what parties should be permitted to donate medication and develop eligibility requirements for parties receiving donated medication. The special commission shall also examine the types of medication to be included within the program with a particular focus on prescription drugs intended to treat chronic illness and cancer.
The special commission shall also recommend guidelines and regulations to ensure public safety and provide estimates of the potential savings for the program’s consumers. Recommendations from the special commission may include but not be limited to requiring donated medication to be sealed and within the recommended period of shelf life or permitting the return and reuse of medications in approved facilities only.
The commission shall consist of the house and senate chairs of the joint committee on health care financing, who shall serve as the co-chairs; the speaker of the house of representatives or a designee; the president of the senate or a designee; the house minority leader or a designee; the senate minority leader or designee; the director of the health policy commission or a designee; the commissioner of the department of public health or a designee; and the executive director of the center for health information and analysis or a designee.
The commission shall submit its report and findings, along with any recommendations, to the house and senate committees on ways and means, the joint committee on health care financing, and the clerks of the house of representatives and senate by February 1, 2022.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.